首页> 美国卫生研究院文献>Journal of Virology >Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes
【2h】

Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes

机译:具有暴露的丙型肝炎病毒抗原决定簇的新型嵌合乙型肝炎表面抗原颗粒的抗原性和免疫原性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The small envelope protein of hepatitis B virus (HBsAg-S) can self-assemble into highly organized virus like particles (VLPs) and induce an effective immune response. In this study, a restriction enzyme site was engineered into the cDNA of HBsAg-S at a position corresponding to the exposed site within the hydrophilic a determinant region (amino acid [aa] 127–128) to create a novel HBsAg vaccine vector allowing surface orientation of the inserted sequence. We inserted sequences of various lengths from hypervariable region 1 (HVR1) of the hepatitis C virus (HCV) E2 protein containing immunodominant epitopes and demonstrated secretion of the recombinant HBsAg VLPs from transfected mammalian cells. A number of different recombinant proteins were synthesized, and HBsAg VLPs containing inserts up to 36 aa were secreted with an efficiency similar to that of wild-type HBsAg. The HVR1 region exposed on the particles retained an antigenic structure similar to that recognized immunologically during natural infection. VLPs containing epitopes from either HCV-1a or -1b strains were produced that induced strain-specific antibody responses in immunized mice. Injection of a combination of these VLPs induced antibodies against both HVR1 epitopes that resulted in higher titers than were achieved by vaccination with the individual VLPs, suggesting a synergistic effect. This may lead to the development of recombinant particles which are able to induce a broad anti-HCV immune response against the HCV quasispecies or other quasispecies-like infectious agents.
机译:乙型肝炎病毒的小包膜蛋白(HBsAg-S)可以自组装成高度组织化的病毒样颗粒(VLP),并诱导有效的免疫反应。在这项研究中,在对应于亲水性决定簇区域(氨基酸[aa] 127–128)内暴露位点的位置,将限制性酶切位点工程化到HBsAg-S的cDNA中,以创建一种新的HBsAg疫苗载体插入序列的方向。我们从含有免疫优势表位的丙型肝炎病毒(HCV)E2蛋白的高变区1(HVR1)插入了各种长度的序列,并证明了转染的哺乳动物细胞中重组HBsAg VLP的分泌。合成了许多不同的重组蛋白,并以与野生型HBsAg相似的效率分泌了含有高达36个氨基酸的插入片段的HBsAg VLP。暴露在颗粒上的HVR1区保留了一种抗原结构,该结构类似于自然感染过程中的免疫学识别。产生了包含来自HCV-1a或-1b菌株的表位的VLP,可在免疫小鼠中诱导菌株特异性抗体反应。注射这些VLP的组合可诱导针对两种HVR1表位的抗体,产生的效价高于通过单独VLP疫苗接种获得的效价,表明具有协同作用。这可能导致重组颗粒的发展,该重组颗粒能够诱导针对HCV准种或其他类似准传染性因子的广泛抗HCV免疫应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号